Virtual only

Learning Objectives

1. The clinical and public health significance of problem behaviors in persons with Autism Spectrum Disorders

2. Benefits and risks of prescribing psychotropic medications for problem behaviors in ASS

3. A pathway for the management of problem behaviors in ASD”

4. Participants will understand the nature of several multifaceted challenges in patients with ASDs/NDDs' experience in the pediatrician's office and other outpatient medical settings.

5. Participants will learn strategies to alleviate ASD-related anxiety symptoms, medical trauma, and other specialized needs in patients (and families) during pediatric visits.

6. Participants will understand the importance of multidisciplinary teams in formulating ASD/NDD-friendly treatment plans, tailored to the individual developmental and emotional profiles of each patient and family.

Resources

Whitaker_AHS Conference_September_27_2025
Autism Comes to the Pediatric Office-Shalita
AAP Statement on White House Autism Announcement
ACOG Affirms Safety and Benefits of Acetaminophen during Pregnancy _ ACOG
Boston_Globe_Article_Raising_Connor
DSM-5-TR_ASD_Worksheet
FDA Initiates Acetaminophen Label Change, Leucovorin Approval for Cerebral Folate Deficiency _ HCPLive
IPB_6 Box Worksheet
Irritability and Problem Behavior in Autism Spectrum Disorder
NDD trifold AID Committee
persico_2021_psychopharmacology_asd
Psychiatric Ass of Severe Bx in ASD and IDD Clinics
Psychiatry
Questions-about-Behavioral-Function-QABF-Google-Docs
Risperidone in Children with Autism and Serious Behavioral Problems

Agnes Whitaker MD

Appearances